Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 2
1986 5
1987 2
1988 6
1989 6
1990 4
1991 5
1992 3
1993 4
1994 1
1995 1
1996 3
1997 1
1998 2
1999 2
2000 6
2001 2
2002 1
2003 2
2004 1
2005 6
2006 3
2007 4
2008 11
2009 7
2010 7
2011 4
2012 15
2013 11
2014 8
2015 17
2016 12
2017 15
2018 9
2019 13
2020 16
2021 11
2022 12
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Results by year

Filters applied: . Clear all
Page 1
Oral apixaban for the treatment of acute venous thromboembolism.
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI; AMPLIFY Investigators. Agnelli G, et al. N Engl J Med. 2013 Aug 29;369(9):799-808. doi: 10.1056/NEJMoa1302507. Epub 2013 Jul 1. N Engl J Med. 2013. PMID: 23808982 Free article. Clinical Trial.
Oral rivaroxaban for symptomatic venous thromboembolism.
EINSTEIN Investigators; Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S. EINSTEIN Investigators, et al. N Engl J Med. 2010 Dec 23;363(26):2499-510. doi: 10.1056/NEJMoa1007903. Epub 2010 Dec 3. N Engl J Med. 2010. PMID: 21128814 Free article. Clinical Trial.
Comment le programme d’investissements d’avenir a-t-il stimulé la recherche et l’innovation en santé ?
Bordet R, Dantonel JC, Vacaresse E, Le Jeunne C, Benhabiles N, Beretz A, Boitard C, Debette S, Duluc G, Froguel P, Garbil B, Lyonnet S, Mahfoudi A, Marquet P, Mouthon F, Rascol O, Richard V, Simon E, Varoqueaux N, Watier H, Zins M. Bordet R, et al. Among authors: le jeunne c. Therapie. 2022 Jan-Feb;77(1):11-17. doi: 10.1016/j.therap.2022.01.005. Epub 2022 Jan 12. Therapie. 2022. PMID: 35101283 French. No abstract available.
Développement des médicaments en pédiatrie : défis existants et recommandations.
Kaguelidou F, Ouèdraogo M, Treluyer JM, Le Jeunne C, Annereau M, Blanc P, Bureau S, Ducassou S, Fiquet B, Flamein F, Gaillard S, Hankard R, Laugel V, Laurent C, Levy C, Marquet T, Polak M, Portefaix A, Vassal G. Kaguelidou F, et al. Among authors: le jeunne c. Therapie. 2023 Jan-Feb;78(1):95-104. doi: 10.1016/j.therap.2022.12.002. Epub 2022 Dec 5. Therapie. 2023. PMID: 36543724 French. No abstract available.
Antibiotic resistance: Tools for effective translational research.
Ploy MC, Andremont A, Valtier B, Le Jeunne C; participants of Giens XXXV Round Table 'Translational research'. Ploy MC, et al. Among authors: le jeunne c. Therapie. 2020 Jan-Feb;75(1):7-12. doi: 10.1016/j.therap.2019.12.003. Epub 2019 Dec 16. Therapie. 2020. PMID: 31987590 Free article. Review. French.
Antibiorésistance : outils pour une recherche translationnelle efficace.
Ploy MC, Andremont A, Valtier B, Le Jeunne C; et les participants à la table ronde Recherche translationnelle des Ateliers de Giens XXXV. Ploy MC, et al. Among authors: le jeunne c. Therapie. 2020 Jan-Feb;75(1):1-6. doi: 10.1016/j.therap.2019.12.001. Epub 2019 Dec 13. Therapie. 2020. PMID: 31932145 Free article. French. No abstract available.
Relapsing polychondritis.
Puéchal X, Terrier B, Mouthon L, Costedoat-Chalumeau N, Guillevin L, Le Jeunne C. Puéchal X, et al. Among authors: le jeunne c. Joint Bone Spine. 2014 Mar;81(2):118-24. doi: 10.1016/j.jbspin.2014.01.001. Epub 2014 Feb 18. Joint Bone Spine. 2014. PMID: 24556284 Review.
Accès précoce aux produits de santé en France : des avancées majeures du CSIS (Conseil stratégique des industries de santé) à concrétiser (modalités, réglementations, financements).
Albin N, Chassagnol F, Bergmann JF; Les participants à la table ronde « Aspects organisationnels et réglementaires » des Ateliers de Giens XXXIV; avec la collaboration de. Albin N, et al. Therapie. 2019 Feb;74(1):87-101. doi: 10.1016/j.therap.2018.11.009. Epub 2018 Dec 6. Therapie. 2019. PMID: 30612729 French. No abstract available.
217 results